Axcella health inc. (AXLA)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18
Operating expenses:
Research and development

44,430

41,658

36,940

30,930

27,594

25,486

0

0

0

General and administrative

16,438

15,781

14,322

11,569

9,742

8,410

0

0

0

Total operating expenses

60,868

57,439

51,262

42,499

37,336

33,896

0

0

0

Loss from operations

-60,868

-57,439

-51,262

-42,499

-37,336

-33,896

0

0

0

Other income (expense):
Interest income

0

-

-

-

0

-

-

-

-

Interest income (expense), net

-

-

0

0

-

-

0

0

0

Other income (expense)

-1,602

-1,598

-1,282

-1,525

-1,664

-2,173

0

0

0

Change in fair value of preferred stock warrant liability

0

51

111

106

102

14

0

0

0

Interest expense

0

-

-

-

0

-

-

-

-

Total other income (expense), net

0

-

-

-

0

-

-

-

-

Net loss and comprehensive loss

-62,473

-59,037

-53,086

-44,566

-39,542

-36,069

0

0

0

Net loss per share, basic and diluted (USD per share)

-0.65

0.58

-0.75

-0.95

-2.43

-2.05

-1.85

-2.15

-1.92

Weighted average common shares outstanding, basic and diluted (in shares)

23,188

23,409

23,083

15,230

4,775

4,781

4,769

4,405

4,229